Comparison of metabolic factors by cookie test between schizophrenic patients during treatments with olanzapine or risperidone

被引：0
|
作者：
Sato, Y. [1 ]
Yasui-Furukori, N. [1 ]
Saito, M. [1 ]
Nakagami, T. [1 ]
Furukori, H. [2 ]
Kaneko, S. [1 ]
机构：
[1] Hirosaki Univ, Dept Neuropsychiat, Hirosaki, Aomori, Japan
[2] Kuroishi Akebono Hosp, Dept Neuropsychiat, Kuroishi, Aomori, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：153 / 154
页数：2
相关论文
共 50 条
  • [41] Antipsychotic Treatment and Metabolic Syndrome: a Comparison Between Schizophrenic and Bipolar Patients
    Prisco, V.
    Boccardi, M.
    Fantini, C.
    Catapano, F.
    Fabrazzo, M.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [42] A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone
    Hatta, Kotaro
    Otachi, Taro
    Sudo, Yasuhiko
    Kuga, Hironori
    Takebayashi, Hiroshi
    Hayashi, Hideaki
    Ishii, Ryusuke
    Kasuya, Masataka
    Hayakawa, Tatsuro
    Morikawa, Fumiyoshi
    Hata, Kazuya
    Nakamura, Mitsuru
    Usui, Chie
    Nakamura, Hiroyuki
    Hirata, Toyoaki
    Sawa, Yutaka
    PSYCHIATRY RESEARCH, 2012, 198 (02) : 194 - 201
  • [43] Antipsychotic treatment and metabolic syndrome: a comparison between schizophrenic and bipolar patients
    Prisco, V.
    Fabrazzo, M.
    Catapano, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S241 - S241
  • [44] Comparative study of efficacy and safety evaluation of olanzapine vs. risperidone in stable schizophrenic patients
    Reena, B.
    Shaktibala, D.
    Dhasmana, D. C.
    Mishra, K. C.
    Kaul, R. K.
    INDIAN JOURNAL OF PHARMACOLOGY, 2007, 39 (01) : 62 - 63
  • [45] Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients
    Smith, RC
    Lindenmayer, J
    Bark, N
    Warner-Cohen, J
    Vaidhyanathaswamy, S
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S404 - S405
  • [46] Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients
    Smith, RC
    Lindenmayer, JP
    Bark, N
    Warner-Cohen, J
    Vaidhyanathaswamy, S
    Khandat, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2005, 8 (02) : 183 - 194
  • [47] A Randomized Controlled Trial of Risperidone and Olanzapine for Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
    Chan, Hung-Yu
    Chiang, Shu-Chuan
    Chang, Ching-Jui
    Gau, Susan S. -F.
    Chen, Jiahn-Jyh
    Chen, Chiung-Hsu
    Hwu, Hai-Gwo
    Lai, Mei-Shu
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (09) : 1226 - 1233
  • [48] Metabolic and inflammatory parameters changes in schizophrenic patients during three months of treatment with long acting risperidone
    Karlovic, D.
    Solter, V.
    Potkonjak, J.
    EUROPEAN PSYCHIATRY, 2007, 22 : S157 - S157
  • [49] Olanzapine versus risperidone in first-episode schizophrenic and schizoform disorders: A double-blind comparison
    Svestka, J
    Synek, O
    Zourkova, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S291 - S291
  • [50] Effect Of Risperidone And Olanzapine On The Metabolic Profile Of Drug Naive Bipolar Disorder Patients
    Gupta, Gajal
    Nagendran, S.
    INDIAN JOURNAL OF PSYCHIATRY, 2022, 64
12345